Chronic GERD: What’s Your Next Step?

Article

GERD of long-standing duration may require on-demand PPI dosing-and evaluation for esophageal damage.

A 58-year-old obese man presents to your clinic for follow-up of GERD. He has had reflux symptoms, characterized by heartburn and regurgitation, for more than 20 years. His reflux worsens when he is supine. His symptoms are generally well-controlled with once-daily PPI dosing, but he occasionally requires an on-demand second dose. Which of the following strategies would you recommend?

A. Refer for upper endoscopy to screen for Barrett esophagus
B. Refer for barium swallow to document GERD
C. Confirm presence of GERD with 24-hour pH study
D. Continue PPI therapy indefinitely and refer only if symptoms change

Please click here for the answer and discussion.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
"Obesity is a Medically Approachable Problem" and Other Lessons with Lee Kaplan, MD, PhD
Related Content
Weight Loss Achievable Despite Interruptions in GLP-1 Medication Access, Study Finds

Weight Loss Achievable Despite Interruptions in GLP-1 Medication Access, Study Finds

Sydney Jennings
July 16th 2025
Article

ENDO 2025. People with inconsistent access to GLP-1 medications still achieved clinically significant weight loss when therapy was combined with lifestyle changes and coaching.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Obesity-Related Cancer Deaths More Than Tripled in the US from 1999 to 2020

Obesity-Related Cancer Deaths More Than Tripled in the US from 1999 to 2020

Sydney Jennings
July 14th 2025
Article

ENDO 2025. Older adults, rural populations, and residents in the Midwest experienced the highest mortality rates, according to new data.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

GLP-1 Therapy for Obesity Requires Substantial Nutritional Framework, Multidisciplinary Support, Joint Advisory Warns

GLP-1 Therapy for Obesity Requires Substantial Nutritional Framework, Multidisciplinary Support, Joint Advisory Warns

Grace Halsey
July 9th 2025
Article

GLP-1 medications are transforming obesity medicine but strong evidence points to a need for integrating nutrition and lifestyle support for lasting weight loss and health benefits.

BF% outperforms BMI in Predicting Morality risk in young adults: New Findings / image courtesy of University of Florida

Body Fat Percentage Outperforms BMI in Predicting Mortality Risk in Young Adults: New Findings

Grace Halsey
July 8th 2025
Article

Body fat percentage and waist circumference were both significantly associated with 15-year all-cause mortality while BMI had no significant association.

© 2025 MJH Life Sciences

All rights reserved.